Sfoglia per Rivista
QUALITY OF LIFE IN PATIENTS WITH LOWER RISK MYELODYSPLASTIC SYNDROMES WITH SEVERE THROMBOCYTOPENIA TREATED WITH ELTROMBOPAG: INTERIM RESULTS OF A RANDOMIZED, PLACEBOCONTROLLED PROSPECTIVE TRIAL
2015-01-01 E. N., Oliva1; * V., Santini2; C., Alati1; G., Sanpaolo3; Poloni, Antonella; A., Molteni5; F., Ronco1; G., Palumbo6; A., Marino1; S., Impera7; E., Balleari8; P., Salutari9; P., Cufari1; I., Santacaterina1; P., Avanzini10; P., Niscola11; A. M., Liberati12; A., Ricco13; F., Morabito14; A., Cortelezzi15; L., Fianchi16; F., Buccisano17; P., Fenaux18; O., Beyne Rauzy19; F., Rodeghiero20; F., Salvi21; R., Latagliata22
Reduced frequencies and functional impairment of dendritic cell subsets and non-classical monocytes in myelodysplastic syndromes
2021-01-01 Van Leeuwen-Kerkhoff, Nathalie; Westers, Theresia M; Poddighe, Pino J; Povoleri, Giovanni A M; Timms, Jessica A; Kordasti, Shahram; De Gruijl, Tanja D; Van de Loosdrecht, Arjan A
TARGETED SEQUENCING ANALYSIS OF COMMONLY MUTATED GENES IN CHRONIC MYELOMONOCYTIC LEUKEMIA USING NGS: IMPACT AND CLINICAL IMPLICATIONS
2015-01-01 Valencia, A; Abdel Wahab, O; Buchi, F; Masala, E; Sanna, A; Gozzini, A; Figueroa, Me; Contini, E; Torricelli, F; B., Allione B; Lunghi, M; Onida, F; Poloni, Antonella; Angelucci, E; Finelli, C; Levis, A; Gioia, D; Bosi, A; Santini, V.
TREATMENT WITH AZACITIDINE REVERSES MESENCHYMAL STEM CELLS DERIVED FROM HIGH RISK MYELODYSPLASTIC PATIENTS TO A NORMAL PHENOTYPE
2015-01-01 Poloni, Antonella; Maurizi, Giulia; Mattiucci, Domenico; Mancini, Stefania; Olivieri, Attilio; Leoni, Pietro
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| QUALITY OF LIFE IN PATIENTS WITH LOWER RISK MYELODYSPLASTIC SYNDROMES WITH SEVERE THROMBOCYTOPENIA TREATED WITH ELTROMBOPAG: INTERIM RESULTS OF A RANDOMIZED, PLACEBOCONTROLLED PROSPECTIVE TRIAL | 1-gen-2015 | E. N., Oliva1; * V., Santini2; C., Alati1; G., Sanpaolo3; Poloni, Antonella; A., Molteni5; F., Ronco1; G., Palumbo6; A., Marino1; S., Impera7; E., Balleari8; P., Salutari9; P., Cufari1; I., Santacaterina1; P., Avanzini10; P., Niscola11; A. M., Liberati12; A., Ricco13; F., Morabito14; A., Cortelezzi15; L., Fianchi16; F., Buccisano17; P., Fenaux18; O., Beyne Rauzy19; F., Rodeghiero20; F., Salvi21; R., Latagliata22 | |
| Reduced frequencies and functional impairment of dendritic cell subsets and non-classical monocytes in myelodysplastic syndromes | 1-gen-2021 | Van Leeuwen-Kerkhoff, Nathalie; Westers, Theresia M; Poddighe, Pino J; Povoleri, Giovanni A M; Timms, Jessica A; Kordasti, Shahram; De Gruijl, Tanja D; Van de Loosdrecht, Arjan A | |
| TARGETED SEQUENCING ANALYSIS OF COMMONLY MUTATED GENES IN CHRONIC MYELOMONOCYTIC LEUKEMIA USING NGS: IMPACT AND CLINICAL IMPLICATIONS | 1-gen-2015 | Valencia, A; Abdel Wahab, O; Buchi, F; Masala, E; Sanna, A; Gozzini, A; Figueroa, Me; Contini, E; Torricelli, F; B., Allione B; Lunghi, M; Onida, F; Poloni, Antonella; Angelucci, E; Finelli, C; Levis, A; Gioia, D; Bosi, A; Santini, V. | |
| TREATMENT WITH AZACITIDINE REVERSES MESENCHYMAL STEM CELLS DERIVED FROM HIGH RISK MYELODYSPLASTIC PATIENTS TO A NORMAL PHENOTYPE | 1-gen-2015 | Poloni, Antonella; Maurizi, Giulia; Mattiucci, Domenico; Mancini, Stefania; Olivieri, Attilio; Leoni, Pietro |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile